首页> 外国专利> Preparing drospirenone, useful e.g. as hormonal contraceptive, comprises reacting dimethylen-androst-4-en-dione with halo propionic acetaldehyde compound, converting dimethylen-hydroxy-(dialkoxypropyl)-androst-4-ene to spirol and oxidizing

Preparing drospirenone, useful e.g. as hormonal contraceptive, comprises reacting dimethylen-androst-4-en-dione with halo propionic acetaldehyde compound, converting dimethylen-hydroxy-(dialkoxypropyl)-androst-4-ene to spirol and oxidizing

机译:制备屈螺酮,有用的作为激素避孕药,包括使二甲基-雄酮-4-烯-二酮与卤代丙醛乙醛化合物反应,将二甲基-羟基-(二烷氧基丙基)-雄酮-4-烯转化为螺线烷并氧化

摘要

Preparing drospirenone (I) comprises either reacting 6,7,15,16-dimethylen-androst-4-en-3,17-dione with a halo propionic acetaldehyde compound (II) to obtain 6,7,15,16-dimethylen-17beta -hydroxy-17alpha -(3,3-dialkoxypropyl)-androst-4-ene (III), converting (III) to dimethylen-17-spirol (IV), and subsequently oxidizing (IV); or reacting 6,7,15,16-dimethylen-androst-4-en-3,17-dione with o-(3-halopropionic acid)-trialkylester compound (V) to obtain 17alpha -(3,3,3-trialkoxypropyl)-17beta -hydroxy-6,7,15,16-dimethylen-androst-4-en-3-one (VI), and converting (VI) to (I). Preparation of drospirenone (I) comprises either reacting 6,7,15,16-dimethylen-androst-4-en-3,17-dione with a halo propionic acetaldehyde compound of formula (X-CH 2-CH 2-CH(OR) 2) (II) to obtain 6,7,15,16-dimethylen-17beta -hydroxy-17alpha -(3,3-dialkoxypropyl)-androst-4-ene (III), converting (III) to dimethylen-17-spirol (IV), and subsequently oxidizing (IV); or reacting 6,7,15,16-dimethylen-androst-4-en-3,17-dione with o-(3-halopropionic acid)-trialkylester compound of formula (X-CH 2-CH 2-C(OR) 3) (V) to 17alpha -(3,3,3-trialkoxypropyl)-17beta -hydroxy-6,7,15,16-dimethylen-androst-4-en-3-one (VI), and converting (VI) to (I). X : Cl, Br, I, mesylate, tosylate or triflate; and R : not defined. An independent claim is included for the preparation of 6beta ,7beta ,15beta ,16beta -dimethylen-androst-4-en-3,17-dione diastereomer comprising cyclopropanation between the positions 6 and 7 of the steroid nucleus containing double bonds of 15beta ,16beta -methylen-androst-4,6-dien-3,17-dione. ACTIVITY : Antiandrogenic; Contraceptive. MECHANISM OF ACTION : None given.
机译:制备屈螺酮(I)包括使6,7,15,16-二甲基-雄酮-4-烯-3,17-二酮与卤代丙醛乙醛化合物(II)反应以获得6,7,15,16-二甲基- 17β-羟基-17α-(3,3-二烷氧基丙基)-雄烷-4-烯(III),将(III)转化为二甲基17-螺环(IV),随后氧化(IV);或使6,7,15,16-二甲基-androst-4-en-3,17-二酮与邻-(3-卤代丙酸)-三烷基酯化合物(V)反应,得到17α-(3,3,3-三烷氧基丙基) )-17β-羟基-6,7,15,16-二甲基-和芳基-4-en-3-one(VI),并将(VI)转化为(I)。 drospirenoneone(I)的制备包括使6,7,15,16-二甲基-雄酮-4-en-3,17-二酮与式(X-CH 2-CH 2-CH(OR )2)(II)获得6,7,15,16-二甲基17beta-羟基-17alpha-(3,3-二烷氧基丙基)-雄烷-4-烯(III),将(III)转化为二甲基17-螺(IV),然后氧化(IV);或使6,7,15,16-二甲基-和芳烃-4-en-3,17-二酮与式(X-CH 2-CH 2-C(OR)的邻-(3-卤代丙酸)-三烷基酯化合物反应3)(V)转化为17α-(3,3,3-三烷氧基丙基)-17beta-羟基-6,7,15,16-二甲基-雄烷-4-en-3-one(VI),并转化(VI)到(I)。 X:Cl,Br,I,甲磺酸盐,甲苯磺酸盐或三氟甲磺酸盐;和R:未定义。包括制备6β,7β,15β,16β-二甲基化-androst-4-en-3,17-二酮非对映异构体的独立权利要求,其在含有15β,16beta双键的类固醇核的6和7位之间具有环丙烷化作用-亚甲基-雄烷-4,6-二烯-3,17-二酮。活动:抗雄激素;避孕药。作用机理:未给出。

著录项

相似文献

  • 专利
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号